Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CP-380736 (PF-00520893) is an epidermal growth factor receptor (EGFR) inhibitor. EGFR is a tyrosine kinase that activates MAPK, JNK, and Akt pathways, and is an important mediator of several types of cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 50.00 | |
10 mg | In stock | $ 75.00 | |
25 mg | In stock | $ 128.00 | |
50 mg | In stock | $ 192.00 | |
100 mg | In stock | $ 287.00 | |
200 mg | In stock | $ 431.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 65.00 |
Description | CP-380736 (PF-00520893) is an epidermal growth factor receptor (EGFR) inhibitor. EGFR is a tyrosine kinase that activates MAPK, JNK, and Akt pathways, and is an important mediator of several types of cancer. |
Synonyms | PF 00520893, CP380736, PF00520893, CP 380736, PF-00520893 |
Molecular Weight | 294.3 |
Formula | C14H18N2O5 |
CAS No. | 179688-29-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 60 mg/ml (203.87 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CP-380736 179688-29-0 Angiogenesis JAK/STAT signaling Tyrosine Kinase/Adaptors EGFR PF 00520893 CP380736 PF00520893 CP 380736 PF-00520893 inhibitor inhibit